Benzinga | Nov 18, 2021 04:12PM EST

Clarus Therapeutics Hldgs Q3 Sales $4.30M Up From $2.22M YoY

Clarus Therapeutics Hldgs (NASDAQ:CRXT) reported $4.30 million in sales this quarter. This is a 93.35 percent increase over sales of $2.22 million the same period last year.